Universitat Internacional de Catalunya   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1997)

Organization Overview

First Clinical Trial
2009
NCT02057926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Juan Gonzalo Olivieri | UicCatalunya | Universitat Internacional de Catalunya | Universitat International Catalunya

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 2)

Communicable Diseases (Phase 4)

Dental Plaque (Phase 2)

Infections (Phase 4)

Joint Diseases (Phase 2)

Mucositis (Phase 4)

Peri-Implantitis (Phase 4)

Surgical Wound (Phase 4)

Surgical Wound Infection (Phase 4)

Temporomandibular Joint Disorders (Phase 2)

Temporomandibular Joint Dysfunction Syndrome (Phase 2)

Wound Infection (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 13